News|Articles|January 2, 2024
Custom Traditional and Multi-Omics Media Development Enhances Antibody Production in CHO Cells (Jan 2024)
Author(s)Thermo Fisher Scientific
This case study summarizes the outcomes of several media optimization projects and how the results helped manufacturers to achieve their desired scale-up goals, including enhancing productivity, maintaining product quality, and potentially improving return on investment (ROI).
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
How the Wegovy Pill Approval Reshapes Solid Dosage Manufacturing Strategy
2
Innovation and Market Exclusivity in the EU
3
FDA Approval of Cytokinetics’ Myqorzo Reflects Specialty Cardio Drug Trend
4
Harnessing Data and Secure Cloud Environments for Global Pharma Solutions
5